Navigation Links
Final Episode of Charlie Rose Science Series Set to Air Monday, April 7th
Date:4/2/2008

- 'The Imperative and Promise of Science' roundtable to focus on the crisis in science education, scientific research, innovation and ethical issues

raised by scientific advances -

NEW YORK, April 2, 2008 /PRNewswire/ --

WHAT: Charlie Rose and co-host Sir Paul Nurse will wrap up the "Charlie

Rose Science Series" with an episode devoted to "The Imperative and

Promise of Science." It will feature scientific leaders who have

inspired a new generation of thinkers. The discussion will focus on

the potential crisis in science education, scientific innovation,

and the role science should play in the 2008 Presidential Election.

WHO: Guests will include:

-- Harold Varmus, MD, 1989 Nobel Laureate in Medicine or Physiology

and President/CEO, Memorial Sloan-Kettering Cancer Center

-- Shirley Ann Jackson, PhD, President, Rensselaer Polytechnic

Institute

-- Lisa Randall, PhD, Professor of Physics, Harvard University

-- Bruce Alberts, PhD, Biochemist, University of California at San

Francisco; Editor-in-Chief, Science Magazine

WHEN: Begins Airing on April 7, 2008 on all PBS stations. Check your

local PBS listings for show times.

DESCRIPTION:

Through 13 episodes -- starting in October 2006 -- the Charlie Rose Science Series, sponsored by Pfizer Inc, featured interviews with great minds in human science research. Along with co-host, Sir Paul Nurse, PhD, Nobel Laureate and President of Rockefeller University, and trailblazing researchers in science and medicine, Charlie Rose explored advances in science and future challenges in understanding the world around us, and improving human health.

As a world leader in research and development, Pfizer is committed to increasing public understanding of science and science education. For more information about The Charlie Rose Science Series or to watch clips from past episodes, please visit http://www.charlierose.com.


'/>"/>
SOURCE Charlie Rose
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Announces Final FDA Approval for Carvedilol Tablets
2. QUANTEL Finalizes the Acquisition of WaveLight Aesthetic GmbH
3. Pro-Consumer Drug Safety Reforms Agreed to in Final FDA Bill; Should End Drug Industry Gaming of Safety System
4. Independence Blue Cross Finalizes New Multi-Year Agreements with Mercy Health System and St. Mary Medical Center
5. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
6. MEDRAD Plant Named IndustryWeek Magazine Award Finalist
7. Innovation and Medical Advances to be Highlighted on Final Day of Inaugural AdvaMed 2007 Conference
8. Seven Finalists Announced for 2007 Insight Award for Customer Advocacy in Healthcare
9. SpectraScience Receives Final European Certification
10. American Idol Finalist and Hickory Records Artist Elliott Yamin to Serve as a Global Ambassador for Inspired by Diabetes Campaign to Help Children with Diabetes
11. Ten Finalists Chosen for 2007 Hutch Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... , ... TherapySites, the leading website and online ... Counseling Association. This new relationship allows TherapySites to continue to extend their ... benefits and promotional offers. , "TCA is extremely excited about this new partnership, ...
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... ... ... blind and certified personal trainer is helping to develop a weight loss fitness plan that ... the two major problems leading the fitness industry today:, , All ... They don’t eliminate all the reasons people quit their exercise program , ...
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
Breaking Medicine Technology: